M&T Bank’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$220K Buy
+2,049
New +$134K ﹤0.01% 1614
2024
Q4
Sell
-636
Closed -$62.7K 1641
2024
Q3
$62.7K Sell
636
-437
-41% -$56.4K ﹤0.01% 1580
2024
Q2
$176K Buy
1,073
+411
+62% +$58.5K ﹤0.01% 1494
2024
Q1
$101K Buy
+662
New +$110K ﹤0.01% 1543
2022
Q2
Sell
-32
Closed -$20K 1619
2022
Q1
$20K Buy
+32
New +$16.5K ﹤0.01% 1480

Other funds holding AGL

M&T Bank's AGL Position: Q2 2026 in Review

M&T Bank opened a new position in Agilon Health (AGL) in Q2 2026: 2,049 shares worth $220K. The stake represents ﹤0.01% of the portfolio and ranks #1614 among its holdings. This is a return to the name: M&T Bank previously reported a position in AGL as recently as Q3 2024.

M&T Bank first reported a position in AGL in Q1 2022 and has held it in 5 quarters since. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • M&T Bank held 2,049 shares of Agilon Health worth $220K as of Q2 2026.
  • Agilon Health was a new M&T Bank position in Q2 2026.
  • Agilon Health made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #1614 holding.
  • M&T Bank first reported a position in Agilon Health in Q1 2022 and has held it in 5 quarters since.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.